Company intelligence / Profile preview

Nodality

South San Francisco, California, United States

Ownership: Private
Employees: ~12
Development stage: Other

Overview

Nodality operates as a platform technology company rather than a traditional drug developer. The company provides functional biology insights through its SCNP technology to pharmaceutical partners for improved drug development outcomes, focusing on disease profiling, drug profiling, clinical development, and life cycle management.

Therapeutic areas: OncologyImmunology
Modalities: Diagnostic
Industry: Molecular Diagnostics

Partnerships

PfizerUCB PharmaJohnson & Johnson

Beyond the preview

Go deeper on Nodality.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nodality.

Explore the full profile